Pangenomic Health Inc. is a precision health company based in Vancouver, Canada, focused on advancing personalized wellness through digital health technologies. It develops and offers a suite of digital platforms — notably the Nara App, a telehealth mental health application providing users with personalized, evidence-based information on natural, non-pharmaceutical treatments tailored to individual genomic, proteomic, and microbiomic data. The company also operates Mindleap, a telehealth platform offering tools and resources to support holistic mental wellness, and MUJN, a clinical decision support system that allows healthcare practitioners to access patient data from mobile apps and diagnostic reports. Founded in 2015 and rebranded from Zetta Capital Corp. in 2021, Pangenomic Health positions itself as a public benefit company aiming to marry nature and science to improve individual health outcomes, particularly in mental health, through its innovative self-care digital platforms.
Markedsdata leveret af TwelveData og Morningstar